Evidence map›Paper›PMID 40423022›Full record

ArticleJournal of imaging2025

Segmentation of Non-Small Cell Lung Carcinomas: Introducing DRU-Net and Multi-Lens Distortion.

Soroush Oskouei, Marit Valla, André Pedersen, Erik Smistad, Vibeke Grotnes Dale, Maren Høibø, Sissel Gyrid Freim Wahl, Mats Dehli Haugum, Thomas Langø, Maria Paula Ramnefjell and 3 more

Abstract read
In one paragraph

Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Soroush OskoueiDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.ORCID 0000-0003-1113-2634
Marit VallaDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.
André PedersenDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.
Erik SmistadDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.
Vibeke Grotnes DaleDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.
Maren HøibøDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.
Sissel Gyrid Freim WahlDepartment of Pathology, St. Olavs Hospital, Trondheim University Hospital, NO-7030 Trondheim, Norway.
Mats Dehli HaugumDepartment of Pathology, St. Olavs Hospital, Trondheim University Hospital, NO-7030 Trondheim, Norway.
Thomas LangøDepartment of Health Research, SINTEF Digital, NO-7465 Trondheim, Norway.
Maria Paula RamnefjellCentre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, NO-5007 Bergen, Norway.ORCID 0009-0000-6142-6353
Lars Andreas AkslenCentre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, NO-5007 Bergen, Norway.ORCID 0000-0003-2710-9543
Gabriel KissCenter for Innovation, Medical Devices and Technology, Research Department, St. Olavs Hospital, Trondheim University Hospital, NO-7491 Trondheim, Norway.
Hanne SorgerDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.ORCID 0000-0002-9968-3491

Funding

Research Council of Norway 223250The Liaison Committee for Education, Research, and Innovation in Central Norway identifiers 2021/928 and 2022/787
6 · The paper itself

Abstract

The increased workload in pathology laboratories today means automated tools such as artificial intelligence models can be useful, helping pathologists with their tasks. In this paper, we propose a segmentation model (DRU-Net) that can provide a delineation of human non-small cell lung carcinomas and an augmentation method that can improve classification results. The proposed model is a fused combination of truncated pre-trained DenseNet201 and ResNet101V2 as a patch-wise classifier, followed by a lightweight U-Net as a refinement model. Two datasets (Norwegian Lung Cancer Biobank and Haukeland University Lung Cancer cohort) were used to develop the model. The DRU-Net model achieved an average of 0.91 Dice similarity coefficient. The proposed spatial augmentation method (multi-lens distortion) improved the Dice similarity coefficient from 0.88 to 0.91. Our findings show that selecting image patches that specifically include regions of interest leads to better results for the patch-wise classifier compared to other sampling methods. A qualitative analysis by pathology experts showed that the DRU-Net model was generally successful in tumor detection. Results in the test set showed some areas of false-positive and false-negative segmentation in the periphery, particularly in tumors with inflammatory and reactive changes. In summary, the presented DRU-Net model demonstrated the best performance on the segmentation task, and the proposed augmentation technique proved to improve the results.

Indexed as

data augmentationdeep learningdigital pathologylung carcinomatumor segmentation

Identifiers

PMID40423022
PMCPMC12112506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.